Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry

Affiliations

• ¹ Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan. Electronic address: ayano.masahiro.811@m.kyushu-u.ac.jp.
• ² Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, 5-30 Kitatakamatsucho, 880-8510 Miyazaki, Japan.
• ³ Center for Rheumatic Diseases, Matsuyama Red Cross Hospital, 1 Bunkyocho, 790-8524 Matsuyama, Japan.
• ⁴ Department of Rheumatology, Shimonoseki City Hospital, 1-13-1 Koyocho, 750-8520 Shimonoseki, Japan.
• ⁵ Department of Rheumatology, Fukuoka Red Cross Hospital, 3-1-1 Ogusu, Fukuoka, Minami-ku, 815-8555, Japan.
• ⁶ Department of Internal Medicine, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Beppu, Tsurumi, 874-0838, Japan.
• ⁷ Department of Rheumatology, Japanese Red Cross Yamaguchi Hospital, 53-1 Yawatanobaba, 753-8519 Yamaguchi, Japan.
• ⁸ Department of Rheumatology, Shin-Kokura Hospital, 1-3-1 Kanada, Kokurakita-ku, 803-8505 Kitakyushu, Japan.
• ⁹ PS Clinic, 6-18 Tenyamachi, Fukuoka, Hakata-ku, 812-0025, Japan.
• ¹⁰ Department of Rheumatology, Saga University Hospital, 5-1-1 Nabeshima, 849-8501 Saga, Japan.
• ¹¹ Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan.
• ¹² Department of Medical Education, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan.